Stock Price
10.10
Daily Change
5.54%
Yearly
-18.48%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Adamas Pharmaceuticals 8.22 0.06 0.74% 91.16%
Aerie Pharmaceuticals 10.10 0.53 5.54% -18.48%
Alimera Sciences 5.23 -0.12 -2.24% 13.70%
Amarin 3.60 0.04 1.12% -26.68%
Antares Pharma 3.23 -0.01 -0.31% 2.87%
Bluebird Bio 10.11 -0.22 -2.13% -77.96%
Cara Therapeutics 13.18 0.60 4.77% -10.28%
Coherus Biosciences 18.57 0.37 2.03% -0.59%
Endo International Ordinary Shares 5.60 -0.24 -4.11% 9.38%
Flexion Therapeutics 9.12 -0.02 -0.22% -17.76%
GW Pharmaceuticals 218.96 0 0% 108.53%
Horizon Pharma 103.76 1.68 1.65% 51.43%
Insmed 27.52 0.40 1.47% -29.69%
Jazz Pharmaceuticals 119.87 -2.54 -2.08% -16.25%
Merck & Co 74.91 0.02 0.03% -8.14%
Mirati Therapeutics 136.77 0.77 0.57% -41.64%
Novartis 73.44 -0.80 -1.08% -9.75%
Iveric bio Inc. 14.62 -0.42 -2.79% 121.85%
Pacira 52.62 1.51 2.95% -12.94%
Regeneron Pharmaceuticals 636.53 -17.87 -2.73% 23.82%
Revance Therapeutics 13.68 1.22 9.79% -43.05%
Supernus Pharmaceuticals 29.97 -0.48 -1.58% 36.35%
Teva Pharmaceutical Industries 8.25 -0.34 -3.96% -12.33%
Bausch Health Companies Inc 30.32 -1.47 -4.62% 25.91%
Zogenix 11.25 -0.15 -1.32% -47.77%
Zoetis 222.04 -1.51 -0.68% 37.61%

Indexes Price Day Year
NASDAQ 15538 -245.14 -1.55% 25.76%
US2000 2199 -43.07 -1.92% 19.76%

Aerie Pharmaceuticals
Aerie Pharmaceuticals, Inc. is an ophthalmic pharmaceutical company. The Company is focused on the discovery, development and commercialization of therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases. The Company’s commercial products include Rhopressa and Rocklatan. Rhopressa is a once-daily eye drop designed to reduce elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Rhopressa is under preclinical and clinical trials. Rhopressa increases the outflow of aqueous humor through the trabecular meshwork (TM), which accounts for approximately 80% of fluid drainage from the healthy eye and is the diseased tissue responsible for elevated IOP in glaucoma. Rocklatan is a once-daily fixed-dose combination of Rhopressa and latanoprost, a drug for the treatment of patients with open-angle glaucoma. Rocklatan is under preclinical and clinical trials to be effective in reducing IOP.